BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vázquez R, Díez-martínez R, Domingo-calap P, García P, Gutiérrez D, Muniesa M, Ruiz-ruigómez M, Sanjuán R, Tomás M, Tormo-mas MÁ, García P. Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain. Microorganisms 2022;10:717. [DOI: 10.3390/microorganisms10040717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Walesch S, Birkelbach J, Jézéquel G, Haeckl FPJ, Hegemann JD, Hesterkamp T, Hirsch AKH, Hammann P, Müller R. Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO Rep 2023;24:e56033. [PMID: 36533629 DOI: 10.15252/embr.202256033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abril AG, Carrera M, Notario V, Sánchez-pérez Á, Villa TG. The Use of Bacteriophages in Biotechnology and Recent Insights into Proteomics. Antibiotics 2022;11:653. [DOI: 10.3390/antibiotics11050653] [Reference Citation Analysis]